Spanish Red Biotech Pipeline

MSD

Vericiguat

Type: Biodrugs/ Drugs
Therapeutic area: Cardiovascular and circulatory systems
Indication: HFrEF - heart failure with reduced ejection fraction (in colaboration with Roche)
Phase: 3Phase III in Spain, 2Phase II, 1Phase I